Valproic Acid

Malignant Glioma

Virginia Commonwealth UniversitySmall moleculePhase 2Dormant

BB

65/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 50/ 100
Competitive Position: 95/ 100

Competitive context

107 Active assets in the Malignant Glioma cohort.

Asset / Sponsor	Phase	Rating
Irinotecan Kailin Yang, MD, PhD	Phase 2	BB
Marizomib Aadi Bioscience, Inc.	Phase 2	BB
Valaciclovir Trogenix ltd	Phase 2	BB
Disodium 4-((Tert-Butylimino)Methyl)Benzene-1,3-Disulfonate N-Oxide Oblato, Inc.	Phase 2	BB
Nogitecan Jeffrey N. Bruce	Phase 2	B

View all 50 →

Same molecule, other indications

Valproic Acid is also rated in:

bipolar I disorderActive

BBB

Indicative · Phase 4

74 / 100

epilepsyActive

BBB

Indicative · Phase 4

73 / 100

bipolar disorderDormant

BBB

Indicative · Phase 4

73 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.